Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway

BACKGROUND: Targeting ribosome biogenesis to activate p53 has recently emerged as a therapeutic strategy in human cancer. Among various ribosomal proteins, RPL11 centralizes the nucleolar stress-sensing pathway by binding MDM2, leading to MDM2 inactivation and p53 activation. Therefore, the identifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Bingwu, Gao, Jian, Zhao, Zhongjun, Zhong, Xuefei, Cui, Hao, Hou, Hui, Zhang, Yanping, Zheng, Junnian, Di, Jiehui, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450376/
https://www.ncbi.nlm.nih.gov/pubmed/36071402
http://dx.doi.org/10.1186/s10020-022-00537-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450376/
https://www.ncbi.nlm.nih.gov/pubmed/36071402
http://dx.doi.org/10.1186/s10020-022-00537-x

Ejemplares similares